Recombinant Macaca fascicularis Abhydrolase domain-containing protein 2 (ABHD2)

Shipped with Ice Packs
In Stock

Description

Functional Roles

ABHD2 exhibits diverse enzymatic and regulatory activities:

Lipid Metabolism

  • Acts as a triacylglycerol (TAG) lipase, hydrolyzing TAGs into free fatty acids and glycerol .

  • Demonstrates ester hydrolase activity against substrates like p-nitrophenyl acetate, butyrate, and palmitate .

  • Regulates mitochondrial phospholipids (e.g., cardiolipin, phosphatidylglycerol) in murine liver, impacting membrane stability .

Progesterone Signaling

  • Functions as a non-genomic progesterone receptor: Progesterone binding activates its lipase activity, degrading endocannabinoids like 2-arachidonoylglycerol (2-AG) .

  • Critical for sperm capacitation by modulating calcium influx via CatSper channels .

Disease Associations

  • COPD: Downregulation correlates with airway remodeling via TGF-β-mediated epithelial-mesenchymal transition (EMT) .

  • Cancer: Modulates anoikis resistance in ovarian cancer and influences metastatic potential .

Biochemical Validation

  • Enzyme Activity: Recombinant ABHD2 expressed in Saccharomyces cerevisiae showed TAG lipase activity (specific activity: 12.5 U/mg) .

  • Mutational Analysis: Ser-207→Ala mutation abolished ligand binding, confirming its catalytic role .

In Vivo Models

  • Knockout Mice:

    • Increased hepatic phosphatidylcholine (+25%) and decreased cardiolipin (−40%) .

    • Disrupted estrous cyclicity and follicular atresia in ovaries .

  • COPD Models: Abhd2-deficient mice exhibited exacerbated emphysema and airway thickening .

Applications in Research

ApplicationUse CaseReference
LipidomicsQuantifying phospholipid remodeling
Reproductive BiologyStudying progesterone-mediated signaling
Drug DiscoveryTargeting TAG lipases for metabolic disorders

Future Directions

  • Therapeutic Targeting: ABHD2 inhibitors/activators could treat COPD, infertility, or lipid disorders .

  • Mechanistic Studies: Elucidate its role in viral infections (e.g., hepatitis B/C) .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type will be determined during the production process. If a specific tag type is required, please inform us, and we will prioritize its development.
Synonyms
ABHD2; QtsA-14549; QtsA-21018; Monoacylglycerol lipase ABHD2; 2-arachidonoylglycerol hydrolase; Abhydrolase domain-containing protein 2; Acetylesterase; Triacylglycerol lipase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-425
Protein Length
full length protein
Species
Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)
Target Names
ABHD2
Target Protein Sequence
MNAMLETPELPAVFDGVKLAAVAAVLYVIVRCLNLKSPTAPPDLYFQDSGLSRFLLKSCP LLTKEYIPPLIWGKSGHIQTALYGKMGRVRSPHPYGHRKFITMSDGATSTFDLFEPLAEH CVGDDITMVICPGIANHSEKQYIRTFVDYAQKNGYRCAVLNHLGALPNIELTSPRMFTYG CTWEFGAMVNYIKKTYPLTQLVVVGFSLGGNIVCKYLGETQANQEKVLCCVSVCQGYSAL RAQETFMQWDQCRRFYNFLMADNMKKIILSHRQALFGDHVKKPQSLEDTDLSRLYTATSL MQIDDNVMRKFHGYNSLKEYYEEESCMRYLHRIYVPLMLVNAADDPLVHESLLTIPKSLS EKRENVMFVLPLHGGHLGFFEGSVLFPEPLTWMDKLVVEYANAICQWERNKSQCSDTEQV EADLE
Uniprot No.

Target Background

Function

Recombinant Macaca fascicularis Abhydrolase domain-containing protein 2 (ABHD2) is a progesterone-dependent acylglycerol lipase. It catalyzes the hydrolysis of the endocannabinoid arachidonoylglycerol (AG) from cell membranes. ABHD2 functions as a progesterone receptor; progesterone binding activates its acylglycerol lipase activity, mediating the degradation of 1-arachidonoylglycerol (1AG) and 2-arachidonoylglycerol (2AG) into glycerol and arachidonic acid (AA). It also exhibits ester hydrolase activity against acetyl, butanoate, and hexadecanoate esters. ABHD2 plays a crucial role in sperm capacitation in response to progesterone by degrading 2AG, an inhibitor of the sperm calcium channel CatSper, thereby enabling calcium influx via CatSper and sperm activation. It may also be involved in smooth muscle cell migration.

Database Links

KEGG: mcf:101867085

UniGene: Mfa.7402

Protein Families
AB hydrolase superfamily, AB hydrolase 4 family
Subcellular Location
Cell membrane; Single-pass type II membrane protein.

Q&A

What is the structural classification of ABHD2?

ABHD2 (abhydrolase domain containing 2) is a protein containing an alpha/beta hydrolase fold, which is a catalytic domain found in a wide range of enzymes . This structural motif is conserved across species and serves as the foundation for the protein's enzymatic activity. The structure consists of parallel beta-sheets surrounded by alpha-helices, creating a characteristic fold that positions the catalytic residues for optimal substrate interaction and catalysis.

What is the amino acid sequence of Macaca fascicularis ABHD2?

The full-length amino acid sequence of Macaca fascicularis ABHD2 (UniProt ID: Q4R2Y9) consists of 425 amino acids. The sequence begins with MNAMLETPELPAVFDGVKLAAVAAVLYVIVRCLNLKSPTAPPDLYFQDSGLSRFLLKSCP and continues through to EADLE at the C-terminus . The protein contains regions critical for enzymatic function, membrane association, and regulatory interactions with other biomolecules.

What are the known physiological functions of ABHD2?

ABHD2 plays several key roles in lipid metabolism, particularly in the synthesis, turnover, and remodeling of phospholipids . It functions as a monoacylglycerol lipase with demonstrated effects on male fertility and ovulation in female mice. In sperm cells, ABHD2 is activated by progesterone and cleaves monoacylglycerols (including 1-arachadonoylglycerol and 2-arachadonoylglycerol) to remove inhibition of the CatSper calcium channel, thereby enabling sperm activation . Additionally, ABHD2 appears to have tissue-specific roles, including potential involvement in mitochondrial lipid regulation.

What are the optimal storage conditions for recombinant ABHD2 protein?

Recombinant ABHD2 protein should be stored at -20°C for regular use, while extended storage requires -20°C to -80°C conditions . It is crucial to avoid repeated freeze-thaw cycles as these can compromise protein integrity and enzymatic activity. For ongoing experiments, working aliquots can be maintained at 4°C for up to one week . When preparing aliquots, use sterile techniques and store in appropriate buffer conditions (typically a Tris-based buffer with 50% glycerol) to maintain stability and prevent protein aggregation or degradation.

How can recombinant ABHD2 be effectively utilized in protein-protein interaction studies?

For protein-protein interaction studies, recombinant ABHD2 can be conjugated to magnetic beads, which offer uniform particle size and narrow size distribution with large surface area for efficient target molecule capture . This approach enables convenient and rapid magnetic separation with high specificity. The pre-coupled magnetic beads can be used in immunoprecipitation and co-precipitation experiments to identify and characterize ABHD2 binding partners. These methods can be integrated with mass spectrometry for comprehensive interactome analysis or used in targeted approaches to validate specific interactions.

What experimental controls should be incorporated when using ABHD2 in enzymatic assays?

When designing enzymatic assays with ABHD2, researchers should include several critical controls:

  • Negative control: Heat-inactivated ABHD2 to demonstrate specificity of enzymatic activity

  • Substrate controls: Varying concentrations of substrates (particularly monoacylglycerols) to establish enzyme kinetics

  • Competitive inhibitors: Known inhibitors of alpha/beta hydrolases to confirm mechanism

  • Positive control: Well-characterized hydrolase with similar substrate specificity

  • Buffer controls: To rule out buffer components influencing observed activity

Additionally, time-course experiments should be performed to establish linear ranges of enzymatic activity, and pH optimization should be conducted to determine optimal reaction conditions.

How does ABHD2 expression influence phospholipid profiles in different tissues?

Studies in knockout mice have revealed tissue-specific effects of ABHD2 on phospholipid profiles. In liver tissue, ABHD2 knockout resulted in increased levels of phosphatidylcholine (PC) and phosphatidylethanolamine (PE), suggesting a role in phospholipid degradation . Interestingly, male knockout mice exhibited decreased levels of mitochondrial lipids, specifically cardiolipin and phosphatidylglycerol . This contrasts with findings in lung tissue, where ABHD2 deficiency led to decreased PC levels in bronchoalveolar lavage fluid .

To effectively study these tissue-specific differences, researchers should employ:

  • Targeted lipidomics approaches focusing on phospholipid species

  • Complementary transcriptomic analysis to identify compensatory mechanisms

  • In vitro enzymatic assays with tissue-derived substrates

  • Subcellular fractionation to determine compartment-specific effects

What approaches can be used to investigate ABHD2 substrate specificity?

Investigating ABHD2 substrate specificity requires a multi-faceted approach:

  • In vitro enzymatic assays: Using purified recombinant ABHD2 with defined substrates to determine kinetic parameters (Km, Vmax, kcat) for various potential substrates

  • Lipid overlay assays: To screen broader classes of potential lipid substrates

  • Activity-based protein profiling: Using activity-based probes specific for serine hydrolases

  • Comparative lipidomics: Between wild-type and ABHD2-deficient samples to identify accumulating substrates

  • Structural modeling and docking studies: To predict substrate binding and catalytic mechanisms

Genetic studies have revealed an inverse relationship between ABHD2 expression and phospholipid levels, indicative of a "substrate signature," suggesting direct involvement in phospholipid degradation pathways .

How can species-specific differences in ABHD2 function be assessed between human and non-human primate models?

Comparing ABHD2 function across species requires:

  • Sequence alignment and structural analysis: To identify conserved domains and species-specific variations

  • Recombinant expression of both variants: Production of both human and Macaca fascicularis ABHD2 under identical conditions

  • Comparative enzymatic assays: Using identical substrates and conditions to detect functional differences

  • Cell-based reconstitution studies: Expressing each variant in ABHD2-knockout cells

  • Phospholipidomic profiling: To identify species-specific effects on the lipidome

When conducting these analyses, researchers should consider that while the catalytic domain is likely conserved, regulatory mechanisms and protein-protein interactions may exhibit species-specific differences that influence function in complex biological systems.

What are the optimal expression systems for producing functional recombinant Macaca fascicularis ABHD2?

Mammalian expression systems, particularly HEK293 cells, are recommended for producing functional recombinant Macaca fascicularis ABHD2 . These systems provide appropriate post-translational modifications and protein folding machinery essential for proper enzyme activity. Consider the following factors when selecting an expression system:

  • Post-translational modifications: Mammalian systems ensure proper glycosylation patterns

  • Protein solubility: Addition of solubility tags (His, GST, etc.) may enhance expression

  • Purification strategy: Incorporation of affinity tags facilitates downstream purification

  • Scale requirements: Transient vs. stable expression depending on protein quantity needed

  • Activity preservation: Gentle purification methods to maintain enzymatic activity

Expression in E. coli systems is possible but may result in inclusion body formation requiring refolding protocols that can compromise activity.

How can ABHD2 activity be reliably quantified in experimental settings?

Reliable quantification of ABHD2 activity can be achieved through several complementary approaches:

  • Fluorogenic substrate assays: Using substrates that release fluorescent products upon hydrolysis

  • Radiometric assays: Employing radiolabeled substrates to measure product formation

  • HPLC-based assays: Separating and quantifying substrate and product

  • Mass spectrometry: For direct detection of lipid substrates and products

  • Coupled enzyme assays: Linking ABHD2 activity to a secondary reaction with easily measurable output

When developing activity assays, researchers should establish linear range, optimize enzyme concentration and reaction time, and validate with known inhibitors. The enzymatic classification (EC= 3.1.1.-) suggests ABHD2 functions as a carboxylic ester hydrolase, which should guide substrate selection .

How should researchers interpret conflicting data regarding ABHD2 function across different tissues?

When confronted with conflicting data regarding ABHD2 function, researchers should:

  • Consider tissue-specific context: ABHD2 may have different roles in liver versus lung tissue, as evidenced by opposite effects on phospholipid levels

  • Examine regulatory networks: Evaluate tissue-specific regulatory mechanisms that may alter ABHD2 function

  • Assess methodology differences: Consider how different experimental approaches (in vivo vs. in vitro) might lead to divergent results

  • Evaluate genetic background effects: Strain differences in mouse models can significantly impact phenotypes

  • Investigate compensatory mechanisms: Related enzymes might compensate for ABHD2 deficiency in certain tissues

Current literature shows that ABHD2 knockout increases phosphatidylcholine in liver but decreases it in lung tissue , suggesting complex tissue-specific regulation that warrants careful experimental design when extrapolating findings across tissues.

What bioinformatic approaches can reveal insights into ABHD2 evolutionary conservation and functional domains?

Bioinformatic analysis of ABHD2 can provide valuable insights through:

  • Multiple sequence alignment: Compare ABHD2 sequences across species to identify conserved regions

  • Phylogenetic analysis: Determine evolutionary relationships and functional divergence

  • Protein domain prediction: Identify functional domains beyond the alpha/beta hydrolase fold

  • Structural modeling: Predict three-dimensional structure based on homology to crystallized hydrolases

  • Molecular dynamics simulations: Investigate potential substrate interactions and catalytic mechanisms

The alpha/beta hydrolase fold is highly conserved across the ABHD family, but substrate specificity determinants may vary. Combining these approaches with experimental validation can elucidate structure-function relationships and guide targeted mutagenesis studies.

What are common pitfalls when working with recombinant ABHD2 and how can they be addressed?

Researchers commonly encounter several challenges when working with recombinant ABHD2:

  • Low enzymatic activity: Ensure proper folding by optimizing expression conditions and purification protocols

  • Protein aggregation: Use appropriate detergents and buffer systems to maintain solubility

  • Inconsistent activity measurements: Standardize assay conditions and enzyme concentration

  • Degradation during storage: Aliquot protein to avoid freeze-thaw cycles and add protease inhibitors

  • Non-specific binding in interaction studies: Include appropriate blocking agents and stringent washing steps

When working with ABHD2-conjugated magnetic beads, avoid freeze-thawing the beads as this can cause aggregation and loss of binding capacity . Additionally, thoroughly equilibrate beads in working buffer before use to ensure optimal binding conditions.

How can researchers differentiate between direct and indirect effects of ABHD2 in complex biological systems?

Distinguishing direct from indirect effects requires:

  • In vitro reconstitution: Use purified components to demonstrate direct enzymatic activity

  • Catalytic site mutations: Create point mutations in catalytic residues to generate enzymatically inactive controls

  • Temporal analysis: Monitor rapid changes that likely represent direct effects versus delayed responses

  • Substrate trapping mutants: Develop variants that bind but do not process substrates

  • Proximity labeling approaches: Identify proteins in direct physical proximity to ABHD2

The genetic evidence showing inverse correlation between ABHD2 expression and phospholipid levels suggests a direct enzymatic relationship , but cell signaling cascades initiated by ABHD2 activity may lead to numerous secondary effects that require careful experimental design to deconvolute.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.